Literature DB >> 16741655

Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.

David L Bourdet1, Dhiren R Thakker.   

Abstract

PURPOSE: The purpose of this work was to investigate the involvement of carrier-mediated apical (AP) uptake and efflux mechanisms in the absorptive intestinal transport of the hydrophilic cationic drug ranitidine in Caco-2 cells.
METHODS: Absorptive transport and AP uptake of ranitidine were determined in Caco-2 cells as a function of concentration. Permeability of ranitidine in the absorptive and secretory directions was assessed in the absence or presence of the P-glycoprotein (P-gp) inhibitor, GW918. Characterization of the uptake mechanism was performed with respect to inhibitor specificity, pH, energy, membrane potential, and Na+ dependence. Efflux from preloaded monolayers was evaluated over a range of concentrations and in the absence or presence of high extracellular ranitidine concentrations.
RESULTS: Saturable absorptive transport and AP uptake of ranitidine were observed with Km values of 0.27 and 0.45 mM, respectively. The ranitidine absorptive permeability increased and secretory permeability decreased upon inhibition of P-gp. AP ranitidine uptake was inhibited in a concentration-dependent fashion by a diverse set of organic cations including tetraethylammonium, 1-methyl-4-phenylpyridinium, famotidine, and quinidine. AP ranitidine uptake was pH and membrane potential dependent and reduced under conditions that deplete metabolic energy. Efflux of [3H]ranitidine across the basolateral membrane was neither saturable as a function of concentration nor trans stimulated by unlabeled ranitidine.
CONCLUSIONS: Saturable absorptive transport of ranitidine in Caco-2 cells is partially mediated via a pH-dependent uptake transporter for organic cations and is subject to attenuation by P-gp. Inhibition and driving force studies suggest the uptake carrier exhibits similar properties to cloned human organic cation transporters. The results also imply ranitidine transport is not solely restricted to the paracellular space.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741655     DOI: 10.1007/s11095-006-0251-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  48 in total

1.  Cimetidine transport in brush-border membrane vesicles from rat small intestine.

Authors:  N Piyapolrungroj; C Li; R L Pisoni; D Fleisher
Journal:  J Pharmacol Exp Ther       Date:  1999-04       Impact factor: 4.030

2.  Intestinal absorptive transport of the hydrophilic cation ranitidine: a kinetic modeling approach to elucidate the role of uptake and efflux transporters and paracellular vs. transcellular transport in Caco-2 cells.

Authors:  David L Bourdet; Gary M Pollack; Dhiren R Thakker
Journal:  Pharm Res       Date:  2006-06-08       Impact factor: 4.200

3.  Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.

Authors:  A Collett; E Sims; D Walker; Y L He; J Ayrton; M Rowland; G Warhurst
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

4.  Saturable transport of H2-antagonists ranitidine and famotidine across Caco-2 cell monolayers.

Authors:  K Lee; D R Thakker
Journal:  J Pharm Sci       Date:  1999-07       Impact factor: 3.534

5.  Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2.

Authors:  A H Dantzig; L Bergin
Journal:  Biochim Biophys Acta       Date:  1990-09-07

6.  The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1.

Authors:  L Zhang; W Gorset; M J Dresser; K M Giacomini
Journal:  J Pharmacol Exp Ther       Date:  1999-03       Impact factor: 4.030

7.  In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

Authors:  F Hyafil; C Vergely; P Du Vignaud; T Grand-Perret
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

8.  Carrier-mediated uptake of H2-receptor antagonists by the rat choroid plexus: involvement of rat organic anion transporter 3.

Authors:  Yoshinori Nagata; Hiroyuki Kusuhara; Shuichi Hirono; Hitoshi Endou; Yuichi Sugiyama
Journal:  Drug Metab Dispos       Date:  2004-09       Impact factor: 3.922

9.  Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.

Authors:  Y Urakami; M Okuda; S Masuda; H Saito; K I Inui
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030

10.  Common characteristics for Na+-dependent sugar transport in Caco-2 cells and human fetal colon.

Authors:  A Blais; P Bissonnette; A Berteloot
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

View more
  8 in total

1.  Intestinal absorptive transport of the hydrophilic cation ranitidine: a kinetic modeling approach to elucidate the role of uptake and efflux transporters and paracellular vs. transcellular transport in Caco-2 cells.

Authors:  David L Bourdet; Gary M Pollack; Dhiren R Thakker
Journal:  Pharm Res       Date:  2006-06-08       Impact factor: 4.200

2.  Effects of acylcarnitines on efflux transporting system in Caco-2 cell monolayers.

Authors:  Mikio Tomita; Nobuyuki Doi; Masahiro Hayashi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-09       Impact factor: 2.441

Review 3.  Variations in amoxicillin pharmacokinetic/pharmacodynamic parameters may explain treatment failures in acute otitis media.

Authors:  Michael E Pichichero; Michael D Reed
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

Review 4.  Clinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions.

Authors:  Marie Lund; Tonny Studsgaard Petersen; Kim Peder Dalhoff
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

5.  The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.

Authors:  Arik Dahan; Hairat Sabit; Gordon L Amidon
Journal:  AAPS J       Date:  2009-03-25       Impact factor: 4.009

6.  Polyethylene glycol 400 enhances the bioavailability of a BCS class III drug (ranitidine) in male subjects but not females.

Authors:  Diane A I Ashiru; Rajesh Patel; Abdul W Basit
Journal:  Pharm Res       Date:  2008-07-04       Impact factor: 4.200

7.  Sex-specific and concentration-dependent influence of Cremophor RH 40 on ampicillin absorption via its effect on intestinal membrane transporters in rats.

Authors:  Heyue Yin; Haibin Shao; Jing Liu; Yujia Qin; Wenbin Deng
Journal:  PLoS One       Date:  2022-02-28       Impact factor: 3.240

8.  Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early-Stage Drug Development.

Authors:  Yvonne E Arnold; Yogeshvar N Kalia
Journal:  Biomedicines       Date:  2020-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.